130 related articles for article (PubMed ID: 9413107)
21. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
22. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.
Roduit C; Bozzotti P; Mielcarek N; Lambert PH; del Giudice G; Locht C; Siegrist CA
Infect Immun; 2002 Jul; 70(7):3521-8. PubMed ID: 12065491
[TBL] [Abstract][Full Text] [Related]
24. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
[TBL] [Abstract][Full Text] [Related]
25. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC
Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656
[TBL] [Abstract][Full Text] [Related]
26. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model.
Kang KR; Huh DH; Kim JA; Kang JH
BMC Immunol; 2021 Oct; 22(1):68. PubMed ID: 34641798
[TBL] [Abstract][Full Text] [Related]
28. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
[TBL] [Abstract][Full Text] [Related]
29. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
30. Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccine.
Vanura H; Just M; Ambrosch F; Berger RM; Bogaerts H; Wynen J; Vandevoorde D; Wiedermann G
Vaccine; 1994; 12(3):210-4. PubMed ID: 8165852
[TBL] [Abstract][Full Text] [Related]
31. Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children.
Kanra G; Ceyhan M; Vandevoorde D; Bogaerts H
Eur J Pediatr; 1993 Jun; 152(6):478-83. PubMed ID: 8335014
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
[TBL] [Abstract][Full Text] [Related]
33. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
Stenger RM; Smits M; Kuipers B; van Gaans-van den Brink J; Poelen M; Boog CJ; van Els CA
Vaccine; 2010 Sep; 28(40):6637-46. PubMed ID: 20637762
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immunity after pertussis vaccination and after natural infection.
Zepp F; Knuf M; Habermehl P; Schmitt HJ; Meyer C; Clemens R; Slaoui M
Dev Biol Stand; 1997; 89():307-14. PubMed ID: 9272364
[TBL] [Abstract][Full Text] [Related]
35. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four- to six-year-olds.
Pichichero ME; Anderson EL; Rennels MB; Edwards KM; England JA
Pediatr Infect Dis J; 2001 Apr; 20(4):427-33. PubMed ID: 11332669
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
Fadugba OO; Wang L; Chen Q; Halasa NB
Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
[TBL] [Abstract][Full Text] [Related]
37. A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
López P; Arguedas Mohs A; Abdelnour Vásquez A; Consuelo-Miranda M; Feroldi E; Noriega F; Jordanov E; B Chir S; Zambrano B
Pediatr Infect Dis J; 2017 Nov; 36(11):e272-e282. PubMed ID: 28719500
[TBL] [Abstract][Full Text] [Related]
38. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
[TBL] [Abstract][Full Text] [Related]
40. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study.
Englund JA; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Anderson EL
Pediatrics; 1994 Jan; 93(1):37-43. PubMed ID: 8265321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
